Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00609219
What this trial is testing

T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC

Who this might be right for
Head and Neck Cancer
Baylor College of Medicine 25
Not applicableLooking for participantsNCT07019870
What this trial is testing

Screening for Early Diagnosis of Nose Cancer

Who this might be right for
Nasopharyngeal Carcinoma
National University Hospital, Singapore 20,000
Large-scale testing (Phase 3)Active Not RecruitingNCT05587374
What this trial is testing

Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Sun Yat-sen University 490
Not applicableActive Not RecruitingNCT05904327
What this trial is testing

Circulating Biomarkers in Oropharyngeal Cancers

Who this might be right for
Oropharynx Squamous Cell CarcinomaOropharynx CancerTonsillar Cancer+1 more
Region Örebro County 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07555860
What this trial is testing

Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 28
Early research (Phase 1)WithdrawnNCT00181220
What this trial is testing

Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Johns Hopkins University
Not applicableUnknownNCT03003182
What this trial is testing

Nasopharyngeal Carcinoma From Guangdong

Who this might be right for
Nasopharyngeal Cancer
Sun Yat-sen University 2,000
Testing effectiveness (Phase 2)Study completedNCT01449942
What this trial is testing

Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Xiangya Hospital of Central South University 40
Not applicableEnded earlyNCT00393224
What this trial is testing

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Who this might be right for
Nasopharyngeal Neoplasms
National Cancer Institute (NCI) 952
Testing effectiveness (Phase 2)UnknownNCT03925090
What this trial is testing

Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC Patients

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 150
Early research (Phase 1)Study completedNCT00516087
What this trial is testing

LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)

Who this might be right for
Nasopharyngeal Carcinoma
Baylor College of Medicine 23
Testing effectiveness (Phase 2)Looking for participantsNCT05508347
What this trial is testing

Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute 170
Testing effectiveness (Phase 2)Looking for participantsNCT06219980
What this trial is testing

SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx

Who this might be right for
SBRT
Sun Yat-sen University 25
Not applicableUnknownNCT02096380
What this trial is testing

The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
First People's Hospital of Foshan 120
Early research (Phase 1)UnknownNCT03925896
What this trial is testing

Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 27
Large-scale testing (Phase 3)Not Yet RecruitingNCT07524413
What this trial is testing

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer
Sun Yat-sen University 514
Not applicableUnknownNCT00232960
What this trial is testing

Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC

Who this might be right for
Oral CancerOropharynx Cancer
Gustave Roussy, Cancer Campus, Grand Paris 310
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Testing effectiveness (Phase 2)UnknownNCT01086488
What this trial is testing

Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Ministry of Health, Malaysia 66
Testing effectiveness (Phase 2)WithdrawnNCT04231864
What this trial is testing

Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer

Who this might be right for
Epstein-Barr Virus PositiveMetastatic Nasopharyngeal CarcinomaRecurrent Nasopharyngeal Carcinoma+4 more
Alain Algazi
Next Page